EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Degradomics for large‐scale mechanistic insights on proteases and proteolysis in human health

Daniel R Martin, Sumit Bhutada, Suneel S Apte iD

The FEBS Journal · 2026-07 · 293 (13) · 3881-3898

DOI: 10.1111/febs.70504 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 23.03.2026. Verfasst von Daniel R Martin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Proteolysis, Peptide Hydrolases, Proteomics, Proteome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, The Marfan Foundation, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tissue breakdown, especially extracellular matrix or secretome breakdown is a significant aspect of physiological remodeling and disease processes in solid organs, with profound structural and regulatory impact. Tissue and circulating proteins undergo breakdown through a chemical process mediated by proteases, that is, hydrolysis of peptide bonds. Proteolysis has immense biological impact because it is irreversible, results in protein inactivation or activation, and can generate fragments with new functions to expand the functional genome. The traditional focus on a few proteases of interest against candidate substrates provided limited insights into the proteolytic landscape of human diseases. In contrast, innovations in protein terminomics workflows, tandem mass spectrometry and data handling now routinely permit identification of proteolytic events and proteases on the proteome scale, the degradome. The unbiased, de novo elucidation of disease degradomes, termed forward degradomics, has increased the number of known in vivo proteolytic events, despite only limited application to human disease to date. In reverse degradomics, activities of proteases are elucidated individually, but also at the proteome scale by digesting protein libraries sourced from tissues and cell secretomes, or by comparing the degradomes of protease‐deficient/overexpressing and parental cells. Integration of forward and reverse degradomes precisely defines protease primary mechanisms in disease. Cross‐disease degradome analysis can define disease‐relevant, protease‐specific biomarkers, identify proteases as appropriate therapeutic targets, and predict cross‐organ impact of protease inhibitors. A systematic effort to map disease degradomes, that is, a prospective human degradome project would generate a comprehensive proteolysis knowledgebase for diagnostics and therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteolysisPeptide HydrolasesProteomicsProteomeHumans

Stichwörter der Autor:innen

mass spectrometryproteaseproteolysisproteomicsterminomics

Substanzen

Peptide HydrolasesProteome

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA.

ORCID-Profile: Suneel S Apte

Förderung

  • NIAMS NIH HHS
  • The Marfan Foundation
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Marfan Foundation

Zitieren

APA

Martin, D. R., Bhutada, S., & Apte, S. S. (2026). Degradomics for large‐scale mechanistic insights on proteases and proteolysis in human health. The FEBS Journal, 293(13), 3881-3898. https://doi.org/10.1111/febs.70504

Vancouver

Martin DR, Bhutada S, Apte SS. Degradomics for large‐scale mechanistic insights on proteases and proteolysis in human health. The FEBS Journal. 2026;293(13):3881-3898. doi:10.1111/febs.70504

BibTeX
@article{Martin2026,
  author = {Martin, Daniel R and Bhutada, Sumit and Apte, Suneel S},
  title = {Degradomics for large‐scale mechanistic insights on proteases and proteolysis in human health},
  journal = {The FEBS Journal},
  year = {2026},
  volume = {293},
  number = {13},
  pages = {3881--3898},
  doi = {10.1111/febs.70504}
}
Kostenlos starten →